Benidipine in Hypertensive And/or Chronic Coronary Syndrome Patients

Launched by THE SOCIETY OF PREVENTION AND AWARENESS OF CARDIOVASCULAR DISEASES · Jan 31, 2025

Keywords

ClinConnect Summary

This clinical trial is focused on studying the effects of a medication called Benidipine in patients who have high blood pressure (hypertension) and/or chronic coronary syndrome, which includes conditions like angina pectoris (chest pain due to heart issues). The goal is to see how well Benidipine works for these patients when prescribed by their doctors in outpatient cardiology clinics in Turkey.

To be eligible for this study, participants should be between 18 and 80 years old and have been receiving Benidipine treatment for at least one month prior to joining the trial. They should have stable mild to moderate high blood pressure or stable angina. Those who are pregnant, have certain severe health conditions, or are participating in other clinical trials will not be able to join. While the trial is not yet recruiting participants, those who do take part can expect to continue their Benidipine treatment and contribute to valuable research that could help improve care for people with similar heart and blood pressure issues.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with hypertension and/or angina pectoris on the background of chronic coronary syndrome who have been receiving Benidipine treatment for at least 1 month and will continue to receive Benidipine treatment
• • Male or female outpatients, 18-80 years of age
• • Patients with mild to moderate essential hypertension who have been receiving or will continue Benidipine treatment for at least 1 month
• • Outpatients with clinically stable angina pectoris and patients who have been receiving or will continue Benidipine treatment for at least 1 month
• • Those who signed the written informed consent form
• Exclusion Criteria:
• • Patients with secondary hypertension
• • Emergency hypertensive patients
• • Having to take other medications during the study that may affect blood pressure
• • Allergic to DHP calcium antagonists
• • Evidence of decompensated congestive heart failure, unstable angina or severe arrhythmia
• • Severe renal or hepatic dysfunction
• • Pregnant or lactating women
• • Participation in other clinical trials within 3 months prior to this study
• • Patients who did not sign the consent form of the study